You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
健帆生物(300529.SZ):HA樹脂血液灌流器被列入《血液灌流在維持性血液透析患者中的臨牀應用上海專家共識》
格隆匯 10-11 17:54

格隆匯10月11日丨健帆生物(300529.SZ)公佈,近日,上海市醫學會腎臟病專科分會制訂的《血液灌流在維持性血液透析患者中的臨牀應用上海專家共識》(簡稱“專家共識”)於《上海醫學》雜誌正式發表。該共識由上海市醫學會腎臟病專科分會主任委員、上海交通大學醫學院附屬新華醫院蔣更如教授等上海22位腎臟病學專家共同制訂,並徵求了全國15位知名腎臟病學專家意見。

專家共識基於應用公司HA樹脂血液灌流器所取得的循證醫學證據,形成血液灌流適宜患者、治療頻次、治療方式和注意事項等推薦意見,用以指導維持性血液透析患者血液灌流的合理、規範化治療。專家共識為臨牀醫生實踐提供有力支撐證據,將有利於健帆HA樹脂血液灌流器的推廣應用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account